- $3.01bn
- $3.34bn
- $2.24bn
- 92
- 43
- 64
- 73
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,956 | 2,072 | 2,214 | 2,223 | 2,236 |
Cost of Revenue | |||||
Gross Profit | 805 | 886 | 1,015 | 972 | 991 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,778 | 1,852 | 1,962 | 2,042 | 2,186 |
Operating Profit | 177 | 219 | 252 | 181 | 50.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 170 | 211 | 280 | 160 | 39.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 128 | 185 | 210 | 118 | -10.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 127 | 184 | 209 | 119 | -9.75 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 127 | 184 | 209 | 119 | -9.75 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.27 | 5.05 | 6.84 | 3.96 | 2.55 |